Clara La Marco

Title: Clara La Marco: Innovator in Ocular Disease Treatment

Introduction

Clara La Marco is a prominent inventor based in Canicatti′, Italy. She has made significant contributions to the field of ocular disease treatment through her innovative research and development of nanostructured formulations.

Latest Patents

Clara La Marco holds a patent for "Nanostructured formulations for the delivery of silibinin and other active ingredients for treating ocular diseases." This patent describes formulations that incorporate silibinin or other active ingredients within lipid nanoparticle systems, specifically of the SLN and NLC type. These formulations are designed to treat neurodegenerative ocular diseases and utilize calixarenes, which may be mucoadhesive, as well as micellar and nanoparticle systems based on amphiphilic inulin copolymers. The versatility of the calixarene compound allows for the charging and releasing of active ingredients that are characterized by low water solubility and low bioavailability.

Career Highlights

Clara La Marco is affiliated with the Distretto Tecnologico Sicilia Micro E Nano Sistemi S.c.a.r.l., where she continues to advance her research in nanotechnology and ocular health. Her work has garnered attention for its potential to improve treatment options for patients suffering from ocular diseases.

Collaborations

Some of her notable coworkers include Anna Rita Blanco and Maria Luisa Bondi. Their collaborative efforts contribute to the innovative research environment at their institution.

Conclusion

Clara La Marco's work in developing nanostructured formulations represents a significant advancement in the treatment of ocular diseases. Her contributions to the field highlight the importance of innovation in healthcare and the potential for new therapies to improve patient outcomes.